{"id":"https://openalex.org/W1970197446","doi":"https://doi.org/10.1021/jm000547o","title":"Identification of Alkylidene Hydrazides as Glucagon Receptor Antagonists","display_name":"Identification of Alkylidene Hydrazides as Glucagon Receptor Antagonists","alternate_titles":[],"publication_year":2001,"publication_date":"2001-08-21","ids":{"openalex":"https://openalex.org/W1970197446","doi":"https://doi.org/10.1021/jm000547o","mag":"1970197446","pmid":"https://pubmed.ncbi.nlm.nih.gov/11543683"},"language":"en","primary_location":{"id":"doi:10.1021/jm000547o","doi":"https://doi.org/10.1021/jm000547o","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm000547o","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1970197446"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5071128028","display_name":"Anthony L Ling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Anthony Ling","raw_affiliation_strings":["Department of Medicinal Chemistry, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., San Diego, CA 92121, USA. anthony.ling@agouron.com","Department of Medicinal Chemistry, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., San Diego, CA 92121, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., San Diego, CA 92121, USA. anthony.ling@agouron.com","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Department of Medicinal Chemistry, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., San Diego, CA 92121, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103585153","display_name":"Yufeng Hong","orcid":"https://orcid.org/0009-0006-6819-6574","observed_orcids":["https://orcid.org/0009-0006-6819-6574"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Yufeng Hong","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101410575","display_name":"Javier Gonz\u00e1lez","orcid":"https://orcid.org/0000-0002-2514-097X","observed_orcids":["https://orcid.org/0000-0002-2514-097X"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Javier Gonzalez","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039904054","display_name":"Vlad E. Gregor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Vlad Gregor","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109929382","display_name":"Alex Polinsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Alex Polinsky","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110104593","display_name":"Atsuo Kuki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Atsuo Kuki","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018256113","display_name":"Shenghua Shi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Shenghua Shi","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023306174","display_name":"Kimberly Teston","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Kimberly Teston","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049386298","display_name":"Douglas E. Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Douglas Murphy","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111577170","display_name":"John W. Porter","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"John Porter","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041537360","display_name":"Dan Kiel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Dan Kiel","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061200524","display_name":"James Lakis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"James Lakis","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018829106","display_name":"Kenna Lynn Anderes","orcid":"https://orcid.org/0000-0002-4515-2011","observed_orcids":["https://orcid.org/0000-0002-4515-2011"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Kenna Anderes","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110097173","display_name":"John Marvin May","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"John May","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088627727","display_name":"Lotte Bjerre Knudsen","orcid":"https://orcid.org/0000-0002-2439-7116","observed_orcids":["https://orcid.org/0000-0002-2439-7116"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Lotte Bjerre Knudsen","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034154367","display_name":"Jesper F. Lau","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]},{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Jesper Lau","raw_affiliation_strings":["Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Medicinal Chemistry, Combinatorial Chemistry Technology, Computational Chemistry, and Research Pharmacology, Pfizer Global Research and Development, La Jolla/Agouron Pharmaceuticals, Inc., 3550 General Atomics Court, San Diego, California 92121","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Departments of Molecular Pharmacology and Medicinal Chemistry IV, Novo Nordisk, Novo Park, DK-2760 Maaloev, Denmark","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5071128028"],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.8817,"has_fulltext":false,"cited_by_count":44,"citation_normalized_percentile":{"value":0.89956743,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"44","issue":"19","first_page":"3141","last_page":"3149"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4699999988079071,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.4699999988079071,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.260699987411499,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11140","display_name":"Natural Antidiabetic Agents Studies","score":0.08950000256299973,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-receptor-antagonists","display_name":"glucagon receptor antagonists","score":0.8769999742507935},{"id":"https://openalex.org/keywords/competitive-antagonism","display_name":"competitive antagonism","score":0.6420000195503235},{"id":"https://openalex.org/keywords/glucose-homeostasis","display_name":"glucose homeostasis","score":0.6159999966621399},{"id":"https://openalex.org/keywords/hit-optimization","display_name":"hit optimization","score":0.5979999899864197},{"id":"https://openalex.org/keywords/nanomolar-affinity","display_name":"nanomolar affinity","score":0.7639999985694885}],"concepts":[{"id":"https://openalex.org/C2778542361","wikidata":"https://www.wikidata.org/wiki/Q14904911","display_name":"Glucagon receptor","level":4,"score":0.8861278295516968},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.8674558401107788},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.8209441900253296},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.6048694849014282},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45893049240112305},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.4104987382888794},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.40283870697021484},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.379050612449646},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.22223761677742004},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.13925117254257202},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.056548357009887695}],"mesh":[{"descriptor_ui":"D000242","descriptor_name":"Cyclic AMP","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005934","descriptor_name":"Glucagon","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006835","descriptor_name":"Hydrazones","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D008099","descriptor_name":"Liver","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D018027","descriptor_name":"Receptors, Glucagon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020650","descriptor_name":"Combinatorial Chemistry Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/jm000547o","doi":"https://doi.org/10.1021/jm000547o","is_oa":false,"landing_page_url":"https://doi.org/10.1021/jm000547o","pdf_url":null,"source":{"id":"https://openalex.org/S162030435","display_name":"Journal of Medicinal Chemistry","issn_l":"0022-2623","issn":["0022-2623","1520-4804"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:11543683","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11543683","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":12,"referenced_works":["https://openalex.org/W1978557997","https://openalex.org/W2019150513","https://openalex.org/W2023003085","https://openalex.org/W2030264781","https://openalex.org/W2053234614","https://openalex.org/W2060381504","https://openalex.org/W2074027399","https://openalex.org/W2094544071","https://openalex.org/W2102597208","https://openalex.org/W2122957764","https://openalex.org/W2469222964","https://openalex.org/W4214692354"],"related_works":["https://openalex.org/W2127258982","https://openalex.org/W1995475257","https://openalex.org/W2914774892","https://openalex.org/W2911866618","https://openalex.org/W2005733030","https://openalex.org/W1998765910","https://openalex.org/W2046017312","https://openalex.org/W2082746738","https://openalex.org/W2074027399","https://openalex.org/W2346326121"],"abstract_inverted_index":{"High":[0],"throughput":[1],"screening":[2],"of":[3,12,23,30,56],"our":[4],"small":[5],"molecule":[6],"combinatorial":[7],"library":[8],"identified":[9],"a":[10,28,57],"class":[11],"benzoylnaphthalenehydrazones":[13],"with":[14,40],"modest":[15],"affinity":[16],"for":[17],"the":[18],"human":[19],"glucagon":[20,51],"receptor.":[21],"Optimization":[22],"this":[24],"initial":[25],"hit":[26],"through":[27],"series":[29],"targeted":[31],"libraries":[32],"and":[33],"traditional":[34],"medicinal":[35],"chemistry":[36],"led":[37],"to":[38],"ligands":[39,48],"nanomolar":[41],"affinities.":[42],"Pharmacological":[43],"evaluation":[44],"demonstrated":[45],"that":[46],"these":[47],"were":[49],"competitive":[50],"receptor":[52],"antagonists.":[53],"Intravenous":[54],"administration":[55],"representative":[58],"benzoylnaphthalenehydrazone":[59],"into":[60],"rats":[61],"attenuated":[62],"glucagon-stimulated":[63],"glucose":[64],"levels.":[65]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1970197446","counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":4},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
